N05.4
Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis
Clinical Classification Guidelines
Medical Intelligence & Overview
Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis (ICD-10 code N05.4) is a kidney condition characterized by inflammation affecting the small blood vessels within the kidneys. This inflammation damages the glomeruli, which are tiny filtering units responsible for cleaning waste and excess fluids from the blood. The condition is classified under a broad category of nephritic syndromes, which often present with symptoms like blood in the urine, swelling, and high blood pressure. Because the precise cause is not specified, it is termed 'unspecified,' but the hallmark is diffuse inflammation involving the endocapillary tissue of the glomeruli, leading to impaired kidney function.
Causes & Symptoms
Clinical Causes: Autoimmune responses where the immune system mistakenly attacks kidney tissues Infections such as streptococcal throat infections or other bacterial and viral illnesses Other systemic conditions like lupus erythematosus that can trigger inflammatory kidney damage Certain medications or toxins that may induce glomerular inflammation Idiopathic cases where no clear cause is identified
Key Symptoms: Blood in the urine (hematuria), giving it a reddish or cola color Swelling (edema), especially around the eyes, ankles, and feet High blood pressure (hypertension) Dark, foamy urine due to excess protein Reduced urine output in some cases Feeling tired or generally unwell Possible flank pain or discomfort in the back
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition involves a combination of medical history review, physical examination, urine tests, blood tests, and kidney biopsy. Urinalysis may reveal blood and protein content indicative of glomerulonephritis. Blood tests can assess kidney function and look for signs of inflammation. A kidney biopsy, where a small tissue sample is examined under a microscope, can confirm the diffuse endocapillary proliferative nature of the glomerulonephritis and exclude other potential causes.
Treatment Protocols: Treatment strategies aim to control symptoms, reduce inflammation, and prevent kidney damage. These may include medications such as corticosteroids to suppress immune response, blood pressure-lowering drugs, and medications to help remove excess fluid. In some cases, treating the underlying cause, if identified, can also help manage the condition. Supportive care includes dietary adjustments and close monitoring of kidney function. Severe cases might require advanced interventions such as dialysis or immunosuppressive therapy under specialist supervision.
Clinical Advice & FAQs
Billing Guidance
Is N05.4 a billable ICD-10 code?
Yes, N05.4 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N05.4?
Clinical documentation must specify the nature of Unspecified nephritic syndrome with diffuse endocapillary proliferative glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference